Drug Search Results
More Filters [+]

Digitoxin

Alternative Names: digitoxin, crystodigin
Latest Update: 2017-09-14
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: ERK Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Austria | Brazil | Canada | Germany | Hungary | Ireland | Pakistan | Peru | Sweden | Taiwan | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Digitoxin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title